NCT01861236View on ClinicalTrials.gov

Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

September 3, 2018

Study Completion Date

September 3, 2018

Conditions
Advanced Hormone Dependent Prostate Cancer
Interventions
DRUG

Firmagon® (degarelix)

Monthly subcutaneous injections

Trial Locations (1)

Unknown

Hospital de Trauma y Emergencia Dr Federico Abete, Ingeniero Pablo Nogués

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY